Tag:

Reata Pharmaceuticals Inc. Cl A

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

FDA approves Reata’s rare disease drug amid questions about changes to the regulatory environment for neuroscience treatments